Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia

Fig. 7

Platelet production induced by 2R13 in mice with 5-FU-induced thrombocytopenia. a Schematic of the experimental design. BALB/c mice were intraperitoneally injected with 0.1% BSA-PBS (control) or 5-FU (150 mg/kg). After 1 h, mice in the control and 5-FU/PBS groups were subcutaneously injected with 0.1% BSA-PBS for seven consecutive days over 14 days. Mice in the 5-FU/rhTPO and 5-FU/2R13 groups were subcutaneously injected with rhTPO for seven consecutive days or once with 2R13, respectively, over 14 days. Quantification of b platelet and c WBC counts. Data are the absolute count mean ± SD (n = 4/group). One-way ANOVA was used for statistical analysis. ***p < 0.001 vs 5-FU/PBS; ##p < 0.01 and ###p < 0.001 vs 5-FU/rhTPO; §§§p < 0.001 vs control; n.s., not significant; L, low concentration; H, high concentration

Back to article page